Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study.
about
Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysisIGF-1, oxidative stress and atheroprotectionMenopause, the metabolic syndrome, and mind-body therapiesPathological impact of SMN2 mis-splicing in adult SMA miceA microsatellite polymorphism in IGF1 gene promoter and longevity in a Han Chinese population.A cross-sectional study of different patterns of oral contraceptive use among premenopausal women and circulating IGF-1: implications for disease riskAssociation of insulin-like growth factor-I with the severity and outcomes of acute ischemic stroke.Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?The Relationship between the Growth Hormone/Insulin-like Growth Factor System and the Histological Features of Nonalcoholic Fatty Liver Disease.Hematopoietic Deficiency of miR-223 Attenuates Thrombosis in Response to Photochemical Injury in Mice.A robust method for genome-wide association meta-analysis with the application to circulating insulin-like growth factor I concentrations.Plasma insulin-like growth factors, insulin-like binding protein-3, and outcome in metastatic colorectal cancer: results from intergroup trial N9741.Increase in insulin-like growth factor 1 (IGF-1) and insulin-like growth factor binding protein 1 after supplementation with selenium and coenzyme Q10. A prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens.International Society of Sports Nutrition Position Stand: protein and exercise.Oestradiol and insulin-like growth factor-1 reduce cell loss after global ischaemia in middle-aged female ratsInsulin like growth factor-I in acute subarachnoid hemorrhage: a prospective cohort study.Will targeting insulin growth factor help us or hurt us?: An oncologist's perspectiveCirculating insulin-like growth factor-1 and its binding protein-3: metabolic and genetic correlates in the communityNADPH oxidases regulate CD44 and hyaluronic acid expression in thrombin-treated vascular smooth muscle cells and in atherosclerosis.IGF-1 has plaque-stabilizing effects in atherosclerosis by altering vascular smooth muscle cell phenotype.Insulin-like growth factors and neoplasia.Are elevated levels of IGF-1 caused by coronary arteriesoclerosis?: Molecular and clinical analysisA genome-wide association study identifies novel loci associated with circulating IGF-I and IGFBP-3Role of insulin-like growth factor 1 in stent thrombosis under effective dual antiplatelet therapy.Effects of the route of oestrogen administration on IGF-1 and IGFBP-3 in healthy postmenopausal women: results from a randomized placebo-controlled study.Genetic studies reveal the role of the endocrine and metabolic systems in aging.Both low and high serum IGF-1 levels associate with increased risk of cardiovascular events in elderly menPsychosocial biomarker research: integrating social, emotional and economic factors into population studies of aging and health.Neuroprotective actions of estradiol and novel estrogen analogs in ischemia: translational implicationsLow circulating insulin-like growth factor I increases atherosclerosis in ApoE-deficient mice.Administration of a Synthetic Peptide Derived from the E-domain Region of Mechano-Growth Factor Delays Decompensation Following Myocardial Infarction.Effects of ACE-inhibition on IGF-1 and IGFBP-3 concentrations in older adults with high cardiovascular risk profile.MicroRNA-133a regulates insulin-like growth factor-1 receptor expression and vascular smooth muscle cell proliferation in murine atherosclerosis.Up-regulation of microRNA-190b plays a role for decreased IGF-1 that induces insulin resistance in human hepatocellular carcinoma.Vasoreparative dysfunction of CD34+ cells in diabetic individuals involves hypoxic desensitization and impaired autocrine/paracrine mechanisms.The relationship between serum insulin-like growth factor I levels and ischemic stroke riskProspective study of insulin-like growth factor-I, insulin-like growth factor-binding protein 3, genetic variants in the IGF1 and IGFBP3 genes and risk of coronary artery disease.Adenoviral-mediated gene transfer of insulin-like growth factor 1 enhances wound healing and induces angiogenesis.Variability and reliability of single serum IGF-I measurements: impact on determining predictability of risk ratios in disease developmentThe Association between Newborn Regional Body Composition and Cord Blood Concentrations of C-Peptide and Insulin-Like Growth Factor I
P2860
Q22252898-E52E8BE9-FC03-41FF-8FAB-653F78A5E9A7Q27694593-706545A3-F5CF-4D58-AE96-80C2B0905D73Q30437308-36A2C021-9AD9-468E-83F8-D842C3298D58Q30551534-F53C4C94-4013-4D3F-B803-D6553C93445EQ30978768-405B8B51-25F2-4829-B093-5AD9EEDFB6CEQ31013593-FEC2E347-E74F-43EC-AE4A-BC9FEB9FDC4BQ33566257-F546B799-1968-4417-8125-5059B7FAD8BBQ33569163-A22AB578-78BB-41EC-96E5-4B2B02578452Q33586839-40273098-3528-4E4E-BC34-6049B42C6009Q33686324-AAF8CDC8-F2D0-4A8E-AA89-1AF30ECEE1CAQ33725695-B6481430-D99E-4C63-A8C5-170FC0875279Q33791812-521F87C4-715D-4CC8-BD46-2ECC49FD154FQ33793116-4574A5EE-FF92-4938-A30E-060CF40996E8Q33814522-32E53FDC-6E28-4452-9585-5E90FF190870Q33821546-5852B20C-E453-4B42-A4CD-9A8B3EAEF3FCQ33919319-647FEF9F-788D-4258-8299-5DB37F3908EDQ33926307-978E2853-0AC3-4089-A9A7-1A30E1B3FAD8Q33936965-132A829A-EBD4-4580-84DF-D95937D05CA3Q34074465-F0E4281F-1F63-4BBA-93D6-1A68D07F58FDQ34161681-3F0E6DA9-8666-493B-A38C-E02C6FD37D8BQ34330521-614353BC-F940-4C55-8FD2-5817B1545292Q34354643-3B867665-283F-4FD6-B6FD-7039C0EBFEACQ34597879-D65DD065-F4E4-4E5A-BD32-45B962D44BAAQ34613424-DFE3AE32-2668-4DDD-9E97-A34DA4078484Q34627034-66854A7D-3820-4B5F-850F-696CB2FFFC1FQ34630640-AB29E724-76BD-49B8-8C33-1BDF0FD320B6Q34647846-B754F1FA-1617-48DF-A7CE-8699C33AD1A3Q34775830-5291C94B-A1B5-48D8-A824-03AE83FEF318Q34827433-F413F0C6-E321-414A-8B4B-0310028FD986Q34979827-F953A3DB-77CF-433A-9921-EEF9A19D723CQ34979969-D425EF64-BF92-4F68-BAD8-1240AFFA2BD3Q35031632-49B4EF93-F3B1-4A3C-B8DE-1D30C749A305Q35100311-A3EDFF59-0F2F-45CC-92A5-FA1BCE7C2421Q35107341-08FB6D69-F5E5-403F-80BF-28D00C45019CQ35142725-6D5B4CBB-84F8-42F9-8AC6-1684EE0B6FB7Q35146896-9229ECC7-7F29-4B0D-82F6-CC0EDDEC60E6Q35193839-B1461A77-5A87-4D26-9159-77418A18815AQ35606971-8434E943-448A-41CC-8D0E-E0F2DA2D086DQ35651618-05A1D9D1-8CC0-43CA-A3AF-BD68578542AFQ35685194-3940AB0A-C9D7-4017-B705-968B589D2831
P2860
Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Low serum insulin-like growth ...... tion-based case-control study.
@en
type
label
Low serum insulin-like growth ...... tion-based case-control study.
@en
prefLabel
Low serum insulin-like growth ...... tion-based case-control study.
@en
P2093
P1433
P1476
Low serum insulin-like growth ...... tion-based case-control study.
@en
P2093
Jesper Gyllenborg
Michael Davidsen
Thomas Scheike
P304
P356
10.1161/01.CIR.0000027563.44593.CC
P407
P577
2002-08-01T00:00:00Z